The effects of CGRP in vascular tissue - Classical vasodilation, shadowed effects and systemic dilemmas

Eur J Pharmacol. 2020 Aug 15:881:173205. doi: 10.1016/j.ejphar.2020.173205. Epub 2020 May 19.

Abstract

Vascular tissue consists of endothelial cells, vasoactive smooth muscle cells and perivascular nerves. The perivascular sensory neuropeptide CGRP has demonstrated potent vasodilatory effects in any arterial vasculature examined so far, and a local protective CGRP-circuit of sensory nerve terminal CGRP release and smooth muscle cell CGRP action is evident. The significant vasodilatory effect has shadowed multiple other effects of CGRP in the vascular tissue and we therefore thoroughly review vascular actions of CGRP on endothelial cells, vascular smooth muscle cells and perivascular nerve terminals. The actions beyond vasodilation includes neuronal re-uptake and neuromodulation, angiogenic, proliferative and antiproliferative, pro- and anti-inflammatory actions which vary depending on the target cell and anatomical location. In addition to the classical perivascular nerve-smooth muscle CGRP circuit, we review existing evidence for a shadowed endothelial autocrine pathway for CGRP. Finally, we discuss the impact of local and systemic actions of CGRP in vascular regulation and protection from hypertensive and ischemic heart conditions with special focus on therapeutic CGRP agonists and antagonists.

Keywords: CGRP; Endothelial cells; Heart; Ischemic heart; Vascular effects; Vascular smooth muscle cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Arteries / drug effects
  • Arteries / innervation
  • Arteries / metabolism*
  • Calcitonin Gene-Related Peptide / metabolism*
  • Calcitonin Gene-Related Peptide / therapeutic use
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology
  • Hormone Antagonists / therapeutic use
  • Humans
  • Receptors, Calcitonin Gene-Related Peptide / drug effects
  • Receptors, Calcitonin Gene-Related Peptide / metabolism*
  • Signal Transduction
  • Vasodilation* / drug effects

Substances

  • Cardiovascular Agents
  • Hormone Antagonists
  • Receptors, Calcitonin Gene-Related Peptide
  • Calcitonin Gene-Related Peptide